Abderezak Zebboudj

5PUBLICATIONS
35CO-AUTHORS
Molecular targetsTumour immunologyInnate immunityPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 19, 2025
RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer.

Zachary Sethna, Pablo Guasp, Charlotte Reiche

|Jan 15, 2025
IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer.

Masataka Amisaki, Abderezak Zebboudj, Hiroshi Yano

|May 10, 2023
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer.

Luis A Rojas, Zachary Sethna, Kevin C Soares

|Jun 03, 2022
ILC2s-Bipartisan politicians in cancer.

Abderezak Zebboudj, Masataka Amisaki, Vinod P Balachandran

|May 19, 2022
Neoantigen quality predicts immunoediting in survivors of pancreatic cancer.

Marta Łuksza, Zachary M Sethna, Luis A Rojas

Pageof 1